Revvity Gross Margin 2012-2026 | RVTY
Current and historical gross margin for Revvity (RVTY) over the last 10 years. The current gross profit margin for Revvity as of June 30, 2026 is %.
| Revvity Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2026-06-30 | $2.91B | $1.60B | 55.01% |
| 2026-03-31 | $2.90B | $1.58B | 54.38% |
| 2025-12-31 | $2.86B | $1.57B | 54.83% |
| 2025-09-30 | $2.81B | $1.56B | 55.31% |
| 2025-06-30 | $2.80B | $1.57B | 55.97% |
| 2025-03-31 | $2.77B | $1.56B | 56.28% |
| 2024-12-31 | $2.76B | $1.54B | 55.83% |
| 2024-09-30 | $2.72B | $1.51B | 55.44% |
| 2024-06-30 | $2.71B | $1.50B | 55.26% |
| 2024-03-31 | $2.73B | $1.51B | 55.50% |
| 2023-12-31 | $2.75B | $1.54B | 55.94% |
| 2023-09-30 | $2.80B | $1.59B | 56.94% |
| 2023-06-30 | $2.84B | $1.63B | 57.31% |
| 2023-03-31 | $3.02B | $1.78B | 58.73% |
| 2022-12-31 | $3.31B | $1.99B | 60.08% |
| 2022-09-30 | $3.00B | $2.00B | 66.48% |
| 2022-06-30 | $3.15B | $2.11B | 67.02% |
| 2022-03-31 | $3.48B | $2.24B | 64.45% |
| 2021-12-31 | $3.83B | $2.43B | 63.60% |
| 2021-09-30 | $3.63B | $2.44B | 67.18% |
| 2021-06-30 | $3.74B | $2.44B | 65.44% |
| 2021-03-31 | $3.32B | $2.21B | 66.47% |
| 2020-12-31 | $2.66B | $1.73B | 64.93% |
| 2020-09-30 | $3.23B | $1.68B | 51.96% |
| 2020-06-30 | $2.98B | $1.50B | 50.24% |
| 2020-03-31 | $2.89B | $1.40B | 48.35% |
| 2019-12-31 | $2.88B | $1.40B | 48.40% |
| 2019-09-30 | $2.84B | $1.37B | 48.47% |
| 2019-06-30 | $2.80B | $1.36B | 48.68% |
| 2019-03-31 | $2.78B | $1.36B | 48.74% |
| 2018-12-31 | $2.78B | $1.34B | 48.25% |
| 2018-09-30 | $2.66B | $1.27B | 47.73% |
| 2018-06-30 | $2.54B | $1.21B | 47.50% |
| 2018-03-31 | $2.39B | $1.13B | 47.17% |
| 2017-12-31 | $2.26B | $1.07B | 47.59% |
| 2017-09-30 | $2.18B | $1.04B | 47.85% |
| 2017-06-30 | $2.14B | $1.02B | 47.81% |
| 2017-03-31 | $2.13B | $1.02B | 47.86% |
| 2016-12-31 | $2.12B | $1.02B | 47.99% |
| 2016-09-30 | $2.00B | $0.96B | 48.02% |
| 2016-06-30 | $2.05B | $0.97B | 47.17% |
| 2016-03-31 | $2.08B | $0.97B | 46.48% |
| 2015-12-31 | $2.11B | $0.97B | 45.84% |
| 2015-09-30 | $2.10B | $0.95B | 45.39% |
| 2015-06-30 | $2.07B | $0.94B | 45.27% |
| 2015-03-31 | $2.07B | $0.93B | 45.21% |
| 2014-12-31 | $2.07B | $0.94B | 45.17% |
| 2014-09-30 | $2.22B | $1.00B | 45.22% |
| 2014-06-30 | $2.20B | $0.99B | 45.18% |
| 2014-03-31 | $2.18B | $0.99B | 45.21% |
| 2013-12-31 | $2.16B | $0.98B | 45.25% |
| 2013-09-30 | $2.13B | $0.96B | 45.05% |
| 2013-06-30 | $2.12B | $0.96B | 45.21% |
| 2013-03-31 | $2.10B | $0.96B | 45.48% |
| 2012-12-31 | $2.11B | $0.96B | 45.68% |
| 2012-09-30 | $2.08B | $0.94B | 45.20% |
| 2012-06-30 | $2.03B | $0.91B | 44.89% |
| 2012-03-31 | $1.98B | $0.88B | 44.35% |
| 2011-12-31 | $1.92B | $0.85B | 44.16% |
| 2011-09-30 | $1.85B | $0.82B | 44.20% |
| 2011-06-30 | $1.81B | $0.80B | 44.32% |
| 2011-03-31 | $1.76B | $0.78B | 44.62% |
| 2010-12-31 | $1.70B | $0.76B | 44.54% |
| 2010-09-30 | $1.54B | $0.71B | 45.99% |
| 2010-06-30 | $1.49B | $0.69B | 46.15% |
| 2010-03-31 | $1.51B | $0.69B | 45.59% |
| 2009-12-31 | $1.55B | $0.70B | 45.29% |
| 2009-09-30 | $1.47B | $0.67B | 45.47% |
| 2009-06-30 | $1.57B | $0.70B | 44.87% |
| 2009-03-31 | $1.64B | $0.73B | 44.68% |
| 2008-12-31 | $1.66B | $0.73B | 44.22% |
| 2008-09-30 | $1.90B | $0.81B | 42.93% |
| 2008-06-30 | $1.85B | $0.79B | 42.47% |
| 2008-03-31 | $1.79B | $0.75B | 41.79% |
| 2007-12-31 | $1.73B | $0.71B | 41.24% |
| 2007-09-30 | $1.63B | $0.67B | 41.13% |
| 2007-06-30 | $1.59B | $0.65B | 40.95% |
| 2007-03-31 | $1.53B | $0.63B | 41.11% |
| 2006-12-31 | $1.48B | $0.61B | 41.30% |
| 2006-09-30 | $1.51B | $0.62B | 40.81% |
| 2006-06-30 | $1.48B | $0.61B | 41.15% |
| 2006-03-31 | $1.47B | $0.61B | 41.33% |
| 2005-12-31 | $1.47B | $0.61B | 41.66% |
| 2005-09-30 | $1.37B | $0.57B | 41.64% |
| 2005-06-30 | $1.35B | $0.56B | 41.67% |
| 2005-03-31 | $1.40B | $0.58B | 41.51% |
| 2004-12-31 | $1.43B | $0.58B | 40.84% |
| 2004-09-30 | $1.39B | $0.58B | 41.77% |
| 2004-06-30 | $1.42B | $0.59B | 41.77% |
| 2004-03-31 | $1.38B | $0.58B | 41.84% |
| 2003-12-31 | $1.34B | $0.56B | 41.89% |
| 2003-09-30 | $1.51B | $0.62B | 40.84% |
| 2003-06-30 | $1.51B | $0.61B | 40.44% |
| 2003-03-31 | $1.51B | $0.62B | 40.71% |
| 2002-12-31 | $1.50B | $0.60B | 40.17% |
| 2002-09-30 | $1.62B | $0.65B | 40.16% |
| 2002-06-30 | $1.60B | $0.66B | 41.18% |
| 2002-03-31 | $1.54B | $0.65B | 42.45% |
| 2001-12-31 | $1.53B | $0.68B | 44.33% |
| 2001-09-30 | $1.47B | $0.65B | 44.54% |
| 2001-06-30 | $1.46B | $0.65B | 44.31% |
| 2001-03-31 | $1.51B | $0.65B | 42.80% |
| 2000-12-31 | $1.57B | $0.65B | 41.36% |
| 2000-09-30 | $1.54B | $0.73B | 47.69% |
| 2000-06-30 | $1.59B | $0.72B | 45.56% |
| 2000-03-31 | $1.52B | $0.67B | 44.31% |
| 1999-12-31 | $1.36B | $0.50B | 36.71% |
| 1999-09-30 | $1.17B | $0.21B | 17.96% |
| 1999-06-30 | $0.97B | $0.00B | 0.31% |
| 1999-03-31 | $0.88B | $-0.16B | -18.22% |
| 1998-12-31 | $0.99B | $-0.05B | -5.15% |
| 1998-09-30 | $1.14B | $0.07B | 6.12% |
| 1998-06-30 | $1.31B | $0.23B | 17.63% |
| 1998-03-31 | $1.47B | $0.38B | 25.85% |
| 1997-12-31 | $1.46B | $0.38B | 25.74% |
| 1997-09-30 | $1.44B | $0.37B | 25.55% |
| 1997-06-30 | $1.44B | $0.37B | 25.61% |
| 1997-03-31 | $1.43B | $0.38B | 26.26% |
| 1996-12-31 | $1.43B | $0.38B | 26.47% |
| 1996-09-30 | $1.44B | $0.38B | 26.62% |
| 1996-06-30 | $1.44B | $0.38B | 26.21% |
| 1996-03-31 | $1.43B | $0.37B | 26.12% |
| 1995-12-31 | $1.42B | $0.37B | 25.93% |
| 1995-09-30 | $1.38B | $-0.32B | -23.23% |
| 1995-06-30 | $1.36B | $-0.34B | -24.76% |
| 1995-03-31 | $1.66B | $-0.34B | -20.41% |
| 1994-12-31 | $2.00B | $-0.34B | -17.16% |
| 1994-09-30 | $2.30B | $0.34B | 14.70% |
| 1994-06-30 | $2.71B | $0.35B | 12.85% |
| 1994-03-31 | $2.73B | $0.35B | 12.84% |
| 1993-12-31 | $2.70B | $0.36B | 13.16% |
| 1993-09-30 | $2.75B | $0.36B | 13.07% |
| 1993-06-30 | $2.75B | $0.37B | 13.35% |
| 1993-03-31 | $2.78B | $0.37B | 13.30% |
| 1992-12-31 | $2.79B | $0.37B | 13.12% |
| 1992-09-30 | $2.74B | $0.36B | 13.18% |
| 1992-06-30 | $2.74B | $0.36B | 13.01% |
| 1992-03-31 | $2.71B | $0.35B | 12.89% |
| 1991-12-31 | $2.69B | $0.35B | 12.98% |
| 1991-09-30 | $2.66B | $0.34B | 12.65% |
| 1991-06-30 | $2.60B | $0.33B | 12.48% |
| 1991-03-31 | $2.55B | $0.31B | 12.31% |
| 1990-12-31 | $2.47B | $0.30B | 12.29% |
| 1990-09-30 | $2.28B | $0.30B | 13.10% |
| 1990-06-30 | $2.02B | $0.29B | 14.35% |
| 1990-03-31 | $1.82B | $0.28B | 15.60% |
| 1989-12-31 | $1.65B | $0.28B | 16.91% |
| 1989-09-30 | $1.64B | $0.28B | 17.12% |
| 1989-06-30 | $1.56B | $0.28B | 17.74% |
| 1989-03-31 | $1.48B | $0.27B | 18.37% |
| 1988-12-31 | $1.41B | $0.27B | 19.00% |
| 1988-09-30 | $1.34B | $0.26B | 19.52% |
| 1988-06-30 | $1.32B | $0.26B | 19.70% |
| 1988-03-31 | $1.29B | $0.25B | 19.39% |
| 1987-12-31 | $1.27B | $0.24B | 19.13% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $14.338B | $2.856B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $142.882B | 25.03 |
| CVS Health (CVS) | United States | $122.206B | 12.19 |
| HCA Healthcare (HCA) | United States | $92.119B | 14.32 |
| Elevance Health (ELV) | United States | $92.005B | 14.44 |
| Cencora (COR) | United States | $62.254B | 19.02 |
| Natera (NTRA) | United States | $49.267B | 0.00 |
| Labcorp Holdings (LH) | United States | $25.572B | 18.03 |
| Viatris (VTRS) | United States | $19.136B | 6.61 |
| Medpace Holdings (MEDP) | United States | $16.619B | 34.90 |
| DiDi Global (DIDIY) | China | $16.275B | 178.51 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.114B | 0.00 |
| Solventum (SOLV) | United States | $15.290B | 12.65 |
| Charles River Laboratories (CRL) | United States | $13.038B | 27.59 |
| ICON (ICLR) | Ireland | $12.935B | 17.58 |
| BrightSpring Health Services (BTSG) | United States | $11.931B | 41.02 |
| Avantor (AVTR) | United States | $10.254B | 18.49 |
| BioMerieux (BMXMF) | France | $10.192B | 0.00 |
| HealthEquity (HQY) | United States | $7.944B | 25.89 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.362B | 72.36 |
| PACS (PACS) | United States | $7.051B | 23.70 |
| Sonic Healthcare (SKHHY) | Australia | $6.687B | 0.00 |
| GETINGE (GNGBY) | Sweden | $6.654B | 18.79 |
| CochLear (CHEOY) | Australia | $6.355B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.282B | 23.76 |
| MiniMed (MMED) | United States | $6.181B | 0.00 |
| Sotera Health (SHC) | United States | $5.285B | 21.79 |
| Concentras Parent (CON) | United States | $4.566B | 22.52 |
| Organon (OGN) | United States | $3.585B | 4.55 |
| CareDx (CDNA) | United States | $2.709B | 308.06 |
| Alignment Healthcare (ALHC) | United States | $2.684B | 68.11 |
| GeneDx Holdings (WGS) | United States | $2.676B | 249.28 |
| Amplifon S.p.A (AMFPF) | Italy | $2.466B | 12.74 |
| Pediatrix Medical (MD) | United States | $2.187B | 12.81 |
| Establishment Labs Holdings (ESTA) | United States | $2.143B | 0.00 |
| Progyny (PGNY) | United States | $2.137B | 30.27 |
| COMPASS Pathways (CMPS) | United Kingdom | $2.013B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $1.914B | 0.00 |
| Surgery Partners (SGRY) | United States | $1.838B | 70.20 |
| Bora Pharmaceuticals, - (BORAY) | Taiwan | $1.695B | 10.18 |
| Freenome (FRNM) | United States | $1.607B | 0.00 |
| Ardent Health (ARDT) | United States | $1.552B | 8.87 |
| Agilon Health (AGL) | United States | $1.551B | 0.00 |
| Nutex Health (NUTX) | United States | $1.486B | 8.52 |
| InnovAge Holding (INNV) | United States | $1.470B | 0.00 |
| Omada Health (OMDA) | United States | $1.255B | 256.25 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.241B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.220B | 23.73 |
| Teladoc Health (TDOC) | United States | $1.181B | 0.00 |
| CryoPort (CYRX) | United States | $0.808B | 0.00 |
| GMR Solutions (GMRS) | United States | $0.716B | 0.00 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| Forward Industries (FWDI) | United States | $0.513B | 0.00 |
| Oncology Institute (TOI) | United States | $0.507B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.504B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.474B | 0.00 |
| SBC Medicals (SBC) | United States | $0.467B | 9.66 |
| Shoulder Innovations (SI) | United States | $0.382B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.377B | 5.47 |
| Embecta (EMBC) | United States | $0.297B | 2.57 |
| Biodesix (BDSX) | United States | $0.289B | 0.00 |
| So-Young (SY) | China | $0.266B | 0.00 |
| LifeMD (LFMD) | United States | $0.166B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.109B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.101B | 0.00 |
| SkinHealth Systems (SKIN) | United States | $0.091B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.079B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.065B | 7.65 |
| Tevogen (TVGN) | United States | $0.049B | 0.00 |
| DocGo (DCGO) | United States | $0.037B | 0.00 |
| Lifeward (LFWD) | United States | $0.020B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.014B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.014B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.011B | 0.00 |
| Ainos (AIMD) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| Aclarion (ACON) | United States | $0.007B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.007B | 0.00 |
| 20/20 Biolabs (AIDX) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| Pomdoctor - (POM) | China | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.004B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |